Veteran private markets investor and operating executive focused on growth-stage technology and healthcare companies. Brett Pohl brings experience in scaling commercial teams, board-level governance and capital raising, with a track record advising startups through Series A–C financings and strategic exits. Previously led business development and corporate strategy roles at software and services firms and has worked closely with venture capital and growth equity funds. Active in board and investor relations, with emphasis on go-to-market execution, revenue operations and M&A preparation. Provides LP-facing reporting and portfolio construction input for institutional and high-net-worth accounts.
Veteran private markets investor and operating executive focused on growth-stage technology and healthcare companies. Brett Pohl brings experience in scaling commercial teams, board-level governance and capital raising, with a track record advising startups through Series A–C financings and strategic exits. Previously led business development and corporate strategy roles at software and services firms and has worked closely with venture capital and growth equity funds. Active in board and investor relations, with emphasis on go-to-market execution, revenue operations and M&A preparation. Provides LP-facing reporting and portfolio construction input for institutional and high-net-worth accounts.
Focuses on growth-stage technology and healthcare investments, prioritizing companies with scalable go-to-market models and clear paths to profitable unit economics. Favors active, board-level engagement to accelerate revenue operations, customer expansion and M&A readiness. Allocates capital with stage-focused discipline—concentrated follow-on reserves for winners—combining sector expertise, commercial scaling playbooks and rigorous diligence on sales motion and GTM metrics. Time horizon is multi-year growth-to-exit, balancing growth orientation with pragmatic capital efficiency and LP reporting transparency.
Focuses on growth-stage technology and healthcare investments, prioritizing companies with scalable go-to-market models and clear paths to profitable unit economics. Favors active, board-level engagement to accelerate revenue operations, customer expansion and M&A readiness. Allocates capital with stage-focused discipline—concentrated follow-on reserves for winners—combining sector expertise, commercial scaling playbooks and rigorous diligence on sales motion and GTM metrics. Time horizon is multi-year growth-to-exit, balancing growth orientation with pragmatic capital efficiency and LP reporting transparency.
| Trades 788 | Longs Won 563/788 71% | Profit Factor 9.62 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $317,396.77 |
| Average Win $127,570.95 | Best Trade (Aug 05) $3.86M | Sharpe Ratio -9.65 |
| Average Loss -$33,198.82 | Worst Trade (Dec 31) -$912,220.32 | Z-Score 0.61 (45.87%) |
| Commissions $0 | Avg. Trade Length 1y 1w 1d | Expectancy $81,665.88 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,618 | 5,056 | 4,494 | 3,933 | 3,371 | 2,809 | 2,247 | 1,685 | 1,124 | 562 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 22,640 | $4.65M | $6.99M | - | $2.35M | 50.46% | -7.354% |
ABBV AbbVie Inc. | 4,815 | $874,880.69 | $1.21M | - | $333,395.41 | 38.11% | -2.513% |
ABT Abbott Laboratories | 8,292 | $1.12M | $876,464.4 | - | -$242,276.52 | -21.66% | +0.085% |
ADI Analog Devices, Inc. | 1,680 | $464,206.02 | $617,248.8 | - | $153,042.78 | 32.97% | +0.202% |
AGG iShares Core U.S. Aggregate Bond ETF | 32,432 | $3.22M | $3.16M | - | -$61,332.39 | -1.91% | -0.256% |
ALL Allstate Corporation | 7,184 | $1.45M | $1.9M | - | $449,650.76 | 31.06% | -0.49% |
AMAT Applied Materials, Inc. | 2,219 | $1.6M | $1.13M | - | -$477,817.25 | -29.78% | +1.176% |
AMD Advanced Micro Devices, Inc. | 7,216 | $1.02M | $3.44M | - | $2.41M | 235.55% | -1.904% |
AMZN Amazon.com Inc | 15,698 | $3.39M | $4.26M | - | $868,339.12 | 25.58% | +15.321% |
ANET Arista Networks, Inc. | 2,457 | $417,395.16 | $443,119.97 | - | $25,724.81 | 6.16% | +5.456% |
APD Air Products and Chemicals, Inc. | 3,010 | $849,000.59 | $887,618.93 | - | $38,618.34 | 4.55% | -1.769% |
APH Amphenol Corporation | 7,606 | $670,544.96 | $611,142.1 | - | -$59,402.86 | -8.86% | +0.551% |
ARTY iShares Future AI & Tech ETF | 80,892 | $4.07M | $5.39M | - | $1.33M | 32.6% | +0.604% |
ASML ASML Holding N.V. New York Registry Shares | 111 | $220,827.83 | $180,819 | - | -$40,008.83 | -18.12% | -1.359% |
AVGO Broadcom Inc. | 7,502 | $1.67M | $2.92M | - | $1.25M | 74.38% | +0.371% |
AXP American Express Company | 1,140 | $385,605 | $383,325 | - | -$2,280 | -0.59% | -0.376% |
BAC Bank of America Corporation | 7,599 | $386,228.16 | $470,758.05 | - | $84,529.89 | 21.89% | +0.356% |
BGRN iShares USD Green Bond ETF | 25,827 | $1.22M | $1.21M | - | -$6,794.44 | -0.56% | -0.141% |
BLK BlackRock, Inc. | 338 | $325,007.28 | $368,551.82 | - | $43,544.54 | 13.4% | -0.727% |
BOTZ Global X Robotics & Artificial Intelligence ETF | 6,473 | $216,571.78 | $227,979.06 | - | $11,407.28 | 5.27% | +0.917% |